Literature DB >> 7191489

Irreversible inhibitors of GABA transaminase induce antinociceptive effects and potentiate morphine.

W R Buckett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7191489     DOI: 10.1016/0028-3908(80)90062-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  7 in total

Review 1.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Effects of an intrathecally administered benzodiazepine receptor agonist, antagonist and inverse agonist on morphine-induced inhibition of a spinal nociceptive reflex.

Authors:  J L Moreau; L Pieri
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

3.  Role of histamine in rodent antinociception.

Authors:  P Malmberg-Aiello; C Lamberti; C Ghelardini; A Giotti; A Bartolini
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

4.  The influence of a GABA transaminase inhibitor, gamma-vinyl GABA, on voluntary morphine consumption in the rat.

Authors:  W R Buckett
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Effects of some GABA-mimetic drugs on the antinociceptive activity of morphine and beta-endorphin in rats.

Authors:  N Zonta; F Zambotti; L Vicentini; R Tammiso; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

Review 6.  Fast synaptic inhibition in spinal sensory processing and pain control.

Authors:  Hanns Ulrich Zeilhofer; Hendrik Wildner; Gonzalo E Yévenes
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

7.  Electroacupuncture at 2/100 hz activates antinociceptive spinal mechanisms different from those activated by electroacupuncture at 2 and 100 hz in responder rats.

Authors:  Josie Resende Torres da Silva; Marcelo Lourenço da Silva; Wiliam Alves Prado
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-16       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.